Cargando…

A Case Report of Treatment With Cariprazine in a Recurrent Psychosis Presumably Induced by Methamphetamine

This case report describes a 31-year-old male patient with psychosis presumably related to methamphetamine-associated psychosis (MAP). Our patient was experiencing persistent symptoms of visual, tactile, and auditory hallucinations after cessation of methamphetamine. He has a medical history of a su...

Descripción completa

Detalles Bibliográficos
Autores principales:	Moran, Robert A, Hastings, Cydne, Della-Pietra, Una, Singh, Chinar, Jacome, Mario
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Cureus 2023
Materias:	Psychiatry
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10650934/ https://www.ncbi.nlm.nih.gov/pubmed/38021522 http://dx.doi.org/10.7759/cureus.47135

Ejemplares similares

Cariprazine Use in Early Psychosis: Three Case Reports
por: Coentre, Ricardo, et al.
Publicado: (2021)

Case Report: Long-Acting Oral Cariprazine
por: Dyrmishi, Emanuela, et al.
Publicado: (2022)

Cariprazine for negative symptoms in early psychosis: a pilot study with a 6-month follow-up
por: Pappa, Sofia, et al.
Publicado: (2023)

Case series: Cariprazine in early-onset schizophrenia
por: Ivanova, Elena, et al.
Publicado: (2023)

A Research of Methamphetamine Induced Psychosis in 1,430 Individuals With Methamphetamine Use Disorder: Clinical Features and Possible Risk Factors
por: Gan, Hong, et al.
Publicado: (2018)

Case report: Successful administration of cariprazine in a young, severely ill patient with recurrent relapses of schizophrenia and persistent negative symptoms
por: Vrublevska, Jelena
Publicado: (2023)

Case Report: Cariprazine in a Patient With Schizophrenia, Substance Abuse, and Cognitive Dysfunction
por: Rodriguez Cruz, Jose, et al.
Publicado: (2021)

Emotion Recognition and Impulsive Choice in Relation to Methamphetamine Use and Psychosis Symptoms
por: Arunogiri, Shalini, et al.
Publicado: (2019)

Refractory Methamphetamine-Induced Psychosis: An Emerging Crisis in Rural America and the Role of Amantadine in Therapeutics
por: Gupta, Mayank, et al.
Publicado: (2022)

Investigating the Role of Serotonin in Methamphetamine Psychosis: Unaltered Behavioral Effects of Chronic Methamphetamine in 5-HT(1A) Knockout Mice
por: Jaehne, Emily J., et al.
Publicado: (2017)

Case Report: Cariprazine Efficacy in Young Patients Diagnosed With Schizophrenia With Predominantly Negative Symptoms
por: Vasiliu, Octavian
Publicado: (2021)

Cariprazine Safety in Adolescents and the Elderly: Analyses of Clinical Study Data
por: Szatmári, Balázs, et al.
Publicado: (2020)

Improving Mood and Cognitive Symptoms in Huntington's Disease With Cariprazine Treatment
por: Molnar, Maria Judit, et al.
Publicado: (2022)

Cariprazine in the Treatment of Bipolar Disorder: Within and Beyond Clinical Trials
por: Do, André, et al.
Publicado: (2021)

The Relationship Between Serum Cytokine Levels and the Degree of Psychosis and Cognitive Impairment in Patients With Methamphetamine-Associated Psychosis in Chinese Patients
por: Yang, Xue, et al.
Publicado: (2020)

A Comparison of Methamphetamine-Induced Psychosis and Schizophrenia: A Review of Positive, Negative, and Cognitive Symptomatology
por: Wearne, Travis A., et al.
Publicado: (2018)

Case Report: Functional and Symptomatic Improvement With Cariprazine in Various Psychiatric Patients: A Case Series
por: Vannucchi, Tommaso, et al.
Publicado: (2022)

Case report: Treatment-resistant schizophrenia with auto-aggressive compulsive behavior—Successful management with cariprazine
por: Renemane, Lubova, et al.
Publicado: (2023)

Dosing Cariprazine Within and Beyond Clinical Trials: Recommendations for the Treatment of Schizophrenia
por: Rancans, Elmars, et al.
Publicado: (2022)

Cariprazine's Potential in Improving Social Dysfunction in Patients With Schizophrenia: A Perspective
por: Morozov, Petr, et al.
Publicado: (2022)

Cariprazine Use in Combination With a Mood Stabilizer in First Episode Mania
por: Palacios-Garrán, Roberto, et al.
Publicado: (2022)

Successful switching from risperidone to cariprazine in a schizophrenic patient with pronounced functional deficit. Case report
por: Sahlsten Schölin, Johan, et al.
Publicado: (2023)

Real-Life Clinical Experience With Cariprazine: A Systematic Review of Case Studies
por: Csehi, Réka, et al.
Publicado: (2022)

Cariprazine on Psychosis: Beyond Schizophrenia – A Case Series
por: Bajouco, Miguel, et al.
Publicado: (2022)

Global improvement with cariprazine in the treatment of bipolar I disorder and schizophrenia: A pooled post hoc analysis
por: Durgam, Suresh, et al.
Publicado: (2017)

Case Report: Severe Side Effects Following Treatment With First Generation Antipsychotics While Cariprazine Leads to Full Recovery
por: Taube, Maris
Publicado: (2021)

Randomized Controlled Trial of Paliperidone Extended Release Versus Risperidone for the Treatment of Methamphetamine-Associated Psychosis in Chinese Patients
por: Wang, Gang, et al.
Publicado: (2020)

Cariprazine treatment in patients with psychosis related to Parkinson’s Disease: a case report.
por: Martín De Argila Lorente, M., et al.
Publicado: (2023)

Treatment Response Distinguishes Persistent Type of Methamphetamine Psychosis From Schizophrenia Spectrum Disorder Among Inmates at Japanese Medical Prison
por: Sekiguchi, Yosuke, et al.
Publicado: (2021)

Associations of executive function and age of first use of methamphetamine with methamphetamine relapse
por: Mu, Lin-Lin, et al.
Publicado: (2022)

Correlates of Aggression in Men With Methamphetamine Use Disorder: Childhood Trauma and Methamphetamine-Use Characteristics
por: Liu, Mengqi, et al.
Publicado: (2022)

The neurobiology of methamphetamine induced psychosis
por: Hsieh, Jennifer H., et al.
Publicado: (2014)

Successful high dose antipsychotic treatment with cariprazine in patients on the schizophrenia spectrum: Real-world evidence from a Spanish hospital setting
por: Galmes, Lluis Niell, et al.
Publicado: (2023)

Methamphetamine-Associated Psychosis
por: Grant, Kathleen M., et al.
Publicado: (2011)

A Case Report of Kratom-Induced Psychosis
por: Cutlip, Hunter A, et al.
Publicado: (2021)

Association Between Alexithymia, Social Support, and Duration of Methamphetamine Use Among Male Methamphetamine-Dependent Patients
por: Cui, Shu, et al.
Publicado: (2021)

Treatment of Symptom Clusters in Schizophrenia, Bipolar Disorder and Major Depressive Disorder With the Dopamine D3/D2 Preferring Partial Agonist Cariprazine
por: Batinic, Borjanka, et al.
Publicado: (2021)

Remission of Persistent Negative Symptoms and Psychosocial Consequences by Combined Clozapine and Cariprazine Treatment in a Patient With Long-Standing Treatment-Resistant Schizoaffective Disorder
por: Bogren, Mats, et al.
Publicado: (2022)

Cariprazine pharmacokinetics
Publicado: (2022)

Commentary: Effect of Low-Frequency Repetitive Transcranial Magnetic Stimulation on Impulse Inhibition Methamphetamine in Abstinent Methamphetamine Patients
por: Wang, Hebin, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_r7546mr7kfbt83bcmh93d6dicb